a b s t r a c t 22q11.2 deletion syndrome (22q11DS) is a genetic disorder that conveys a significant risk for the development of social behavior disorders, including autism and schizophrenia. Also known as DiGeorge syndrome, 22q11DS is the second most common genetic disorder and is characterized by an elevated risk for immune dysfunction, up to 77% of individuals have an identifiable immune deficiency. We hypothesize that this immune dysfunction could contribute to the elevated risk of impaired social behavior seen in 22q11DS. The current study begins to elucidate these immune deficits and link them with the behavioral alterations associated with the disorder. Serum concentrations of a series of cytokines were examined, using a multiplex immunoassay, in sixteen individuals with 22q11DS and screened for autismrelated behavior using the Autism Diagnostic Interview-Revised (ADI-R). This preliminary study examined correlations between specific immune proteins and each of the ADI-R algorithm scores (social, communication, and repetitive behavior). The inflammatory cytokine IL-1b, as well as the ratio between the inflammatory cytokine IL-6 and the anti-inflammatory cytokine IL-10, were correlated with social scores (r = 0.851, p = 0.004; r = 0.580, p = 0.018). In addition, the inflammatory cytokines interferon gamma and IL-12p70 were correlated with repetitive behaviors (r = 0.795, p = 0.033; r = 0.774, p = 0.002). Interestingly, IL-12 has been reported to be increased in autistic children. These data show a positive association between severity of autism-related behaviors and level of serum concentrations of inflammatory cytokines in individuals with 22q11DS, providing a basis for further inquiry.
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Introduction
22q11.2 deletion syndrome (22q11DS) is the second most common childhood genetic disorder, behind Down's syndrome (1:4000 births) (Oskarsdottir et al., 2004) . 22q11DS, also known as DiGeorge syndrome and velo-cardio-facial syndrome, is characterized by a spontaneous 3MB hemizygous deletion on the long arm of chromosome 22 and results in a complex medical phenotype which may involve heart and palatal defects, facial dysmorphology, and thymic dysfunction (McDonald-McGinn et al., 1993) . 22q11DS conveys a significant risk for the development of social behavior deficits, including autism-spectrum and schizophrenia-spectrum disorders. Research studies find that autism spectrum disorders occur in 14-45% of clinically-ascertained individuals with 22q11DS, as compared with >0.9% in the general population (McDonald-McGinn and Sullivan, 2011) . Likewise, schizophrenia occurs in up to 33% of such individuals, which is 25-31 times higher than the general population (Drew et al., 2011) . In fact, 22q11DS is the number one genetic risk factor for schizophrenia (Liu et al., 2002) . Notably, schizophrenia disorder 4 is one of the genes deleted from chromosome 22 in the syndrome.
There is evidence that immune disruptions lead to alterations in behavioral function and the emergence of neurodevelopmental and psychiatric disorders. Schizophrenia has been strongly linked to immune dysfunction. Indeed, some of the very first evidence linking prenatal immune function to neuropsychiatric outcomes was identified by researchers studying schizophrenia who found that the risk of disease was increased 7-fold for influenza exposure during the first trimester and that influenza exposure during early to mid-pregnancy increased the risk of schizophrenia 3-fold (Brown et al., 2004) . Other maternal infections that have been linked to the development of schizophrenia include non-specific bacterial infections, Toxoplasma gondii, and herpes simplex virus type 2 (Sorensen et al., 2009; Mortensen et al., 2010; Pedersen et al., 2011) . In addition, there is growing evidence for additional immune disturbances among schizophrenic patients. Higher concentrations of constitutively active and endotoxin-induced
